Monte Rosa Therapeutics, Inc. (GLUE)
23.99
+0.27
(+1.14%)
USD |
NASDAQ |
Jan 13, 16:00
24.00
+0.01
(+0.04%)
After-Hours: 20:00
Monte Rosa Therapeutics EPS Diluted (Quarterly): -0.3287 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0558 |
| CorMedix, Inc. | 1.259 |
| Indivior PLC | 0.3256 |
| Mirum Pharmaceuticals, Inc. | 0.051 |
| Innovative Eyewear, Inc. | -0.3771 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.08M |
| Revenue (Quarterly) | 12.77M |
| Total Expenses (Quarterly) | 39.85M |
| Enterprise Value | 1.211B |
| Gross Profit Margin (Quarterly) | 83.59% |
| Profit Margin (Quarterly) | -212.1% |
| Earnings Yield | 1.27% |
| Operating Earnings Yield | 0.46% |
| Normalized Earnings Yield | 1.273 |